Myocardial fibrosis is associated with biventricular dysfunction in patients with hypertrophic cardiomyopathy

Echocardiography

Volumn 29, Issue 4, 2012, Pages 438-444

  Prinz, Christian ^a   Van Buuren, Frank ^a   Faber, Lothar ^a   Bitter, Thomas ^a   Bogunovic, Nikola ^a   Burchert, Wolfgang ^b   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

hypertrophic cardiomyopathy; late enhancement; MRI; myocardial fibrosis; speckle tracking echocardiography

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FAILURE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LUNG ARTERY PRESSURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; ENDOMYOCARDIAL FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION;

EID: 84859749127     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01588.x     Document Type: Article

References (29)

1. Teare D,: Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958; 20: 1-18.
2. Braunwald E, Lambrew CT, Rockoff SD, et al,: Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964; 30: 3-119.
3. Maron BJ,: Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133. (Pubitemid 27313649)
4. Elliott PM, Poloniecki J, Dickie S, et al,: Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
5. Kwon DH, Smedira NG, Rodriguez ER, et al,: Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: Correlation with histopathology and prevalence or ventricular tachycardia. J Am Coll Cardiol 2009; 54: 242-249.
6. Wilson JM, Villareal RP, Hariharan R, et al,: Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 2002; 29: 176-180. (Pubitemid 35006923)
7. Adabag AS, Maron BJ, Appelbaum E, et al,: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1369-1374. (Pubitemid 351443083)
8. Rubinshtein R, Glockner JF, Ommen SR, et al,: Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010; 3: 51-58.
9. Bruder O, Wagner A, Jensen CJ, et al,: Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56: 875-887.
10. O'Hanlon R, Grasso A, Roughton M, et al,: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56: 867-874.
11. Kumar A, Abdel-Aty H, Taylor A, et al,: Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006; 48: 1969-1976. (Pubitemid 44767976)
12. Larose E, Ganz P, Reynolds HG, et al,: Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myorcardial infarction. J Am Coll Cardiol 2007; 49: 855-862.
13. Yang H, Sun JP, Lever HM, et al,: Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2003; 16: 233-239. (Pubitemid 36397617)
14. Saccheri MC, Cianciulli TF, Lax JA, et al,: Impaired myocardial function in hypertrophic cardiomyopathy. Echocardiography 2009; 26: 657-664.
15. Nesbitt GC, Mankad S,: Strain and strain rate in cardiomyopathy. Echocardiography 2009; 26: 337-344.
16. Amundsen BH, Helle-Valle T, Edvardsen T, et al,: Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2003; 42: 1687-1713.
17. Correia E, Rodrigues B, Santos LF, et al,: Longitudinal left ventricular strain in hypertrophic cardiomyopathy: Correlation with nonsustained ventricular tachycardia. Echocardiography 2011; 28: 709-714.
18. Maron MS, Appelbaum E, Harrigan CJ, et al,: Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008; 1: 184-191.
19. Olivotto I, Maron BJ, Appelbaum E, et al,: Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 2010; 106: 261-267.
20. Propescu BA, Andrade MJ, Badano LP, et al,: European Association of Echocardiography: European Association of Echocardiography recommandations for training, competence, and quality improvement in echocardiography. Eur J Echocardiogr 2009; 10: 893-905.
21. Lang RM, Bierig M, Devereux RB, et al,: American Society of Echocardiography As Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology: Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108. (Pubitemid 43257193)
22. Devereux RB, Alonso DR, Lutas EM, et al,: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. (Pubitemid 16119719)
23. Bondarenko O, Beek AM, Hofman MB, et al,: Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005; 7: 481-485. (Pubitemid 40563339)
24. Isner JM, Roberts WC,: Right ventricular infarction complicating left ventricular infarction secondary to coronary heart disease: frequency, location, associated findings and significance from analysis of 236 necropsy patients with acute or healed myocardial infarction. Am J Cardiol 1978; 42: 885-894.
25. Seidman CE, Seidman JG,: Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: A personal history. CircRes 2011; 108: 743-750.
26. Girolami F, Ho CY, Semsarian C, et al,: Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 2010; 55: 1444-1453.
27. Masci PG, Francone M, Desmet W, et al,: Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction. Circulation 2010; 122: 1405-1412.
28. D'Andrea A, Caso P, Bassone E, et al,: Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: An ultrasound speckle-tracking two-dimensional strain analysis. Eur J Echocardiogr 2010; 11: 492-500.
29. Maeda M, Yamakado J, Nakano T,: Right ventricular diastolic function in patients with hypertrophic cardiomyopathy. An invasive study. Jpn Circ J 1999; 63: 681-687. (Pubitemid 29436662)